238 related articles for article (PubMed ID: 23182943)
21. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
22. Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug-eluting stent implantation: insight from intravascular ultrasound volumetric analysis.
Ito T; Tani T; Fujita H; Ohte N
Int J Cardiol; 2014 Sep; 176(2):399-404. PubMed ID: 25125008
[TBL] [Abstract][Full Text] [Related]
23. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance.
Amano T; Matsubara T; Uetani T; Nanki M; Marui N; Kato M; Yoshida T; Arai K; Yokoi K; Ando H; Kumagai S; Ishii H; Izawa H; Hotta N; Murohara T
JACC Cardiovasc Imaging; 2008 Jan; 1(1):39-45. PubMed ID: 19356403
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome component combinations and chronic kidney disease: the severance cohort study.
Cho JA; Lee SJ; Reid EA; Jee SH
Maturitas; 2013 May; 75(1):74-80. PubMed ID: 23489551
[TBL] [Abstract][Full Text] [Related]
25. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
[TBL] [Abstract][Full Text] [Related]
26. Rates of future hemodialysis risk and beneficial outcomes for patients with chronic kidney disease undergoing recanalization of chronic total occlusion.
Shimura T; Yamamoto M; Tsuchikane E; Teramoto T; Kimura M; Matsuo H; Kawase Y; Suzuki Y; Kano S; Habara M; Nasu K; Kinoshita Y; Terashima M; Matsubara T; Suzuki T
Int J Cardiol; 2016 Nov; 222():707-713. PubMed ID: 27521544
[TBL] [Abstract][Full Text] [Related]
27. Nonculprit coronary plaque characteristics of chronic kidney disease.
Kato K; Yonetsu T; Jia H; Abtahian F; Vergallo R; Hu S; Tian J; Kim SJ; Lee H; McNulty I; Lee S; Uemura S; Jang Y; Park SJ; Mizuno K; Yu B; Jang IK
Circ Cardiovasc Imaging; 2013 May; 6(3):448-56. PubMed ID: 23536265
[TBL] [Abstract][Full Text] [Related]
28. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
[TBL] [Abstract][Full Text] [Related]
29. Impact of Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions (from the Japanese Multicenter Registry).
Naganuma T; Tsujita K; Mitomo S; Ishiguro H; Basavarajaiah S; Sato K; Kobayashi T; Obata J; Nagamatsu S; Yamanaga K; Komura N; Sakamoto K; Yamamoto E; Izumiya Y; Kojima S; Kaikita K; Ogawa H; Nakamura S
Am J Cardiol; 2018 Jun; 121(12):1519-1523. PubMed ID: 29627112
[TBL] [Abstract][Full Text] [Related]
30. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
[TBL] [Abstract][Full Text] [Related]
31. Impact of culprit plaque volume and composition on myocardial microcirculation following primary angioplasty in patients with ST-segment elevation myocardial infarction: virtual histology intravascular ultrasound analysis.
Ohshima K; Ikeda S; Kadota H; Yamane K; Izumi N; Ohshima K; Hamada M
Int J Cardiol; 2013 Aug; 167(3):1000-5. PubMed ID: 22481047
[TBL] [Abstract][Full Text] [Related]
32. Impact of cigarette smoking on coronary plaque composition.
Kumagai S; Amano T; Takashima H; Waseda K; Kurita A; Ando H; Maeda K; Ito Y; Ishii H; Hayashi M; Yoshikawa D; Suzuki S; Tanaka A; Matsubara T; Murohara T
Coron Artery Dis; 2015 Jan; 26(1):60-5. PubMed ID: 25171387
[TBL] [Abstract][Full Text] [Related]
33. Relation between estimated glomerular filtration rate and composition of coronary arterial atherosclerotic plaques.
Hayano S; Ichimiya S; Ishii H; Kanashiro M; Watanabe J; Kurebayashi N; Yoshikawa D; Amano T; Matsubara T; Murohara T
Am J Cardiol; 2012 Apr; 109(8):1131-6. PubMed ID: 22245411
[TBL] [Abstract][Full Text] [Related]
34. Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction.
Kim CS; Choi JS; Bae EH; Ma SK; Ahn YK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Kim SW;
Metabolism; 2013 May; 62(5):669-76. PubMed ID: 23218489
[TBL] [Abstract][Full Text] [Related]
35. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
[TBL] [Abstract][Full Text] [Related]
36. Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study).
Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Akkerhuis KM; Kardys I; de Boer SP; Langstraat JS; Regar E; van Geuns RJ; Serruys PW; Boersma E
Am J Cardiol; 2014 Nov; 114(10):1497-503. PubMed ID: 25248815
[TBL] [Abstract][Full Text] [Related]
37. Can metabolic syndrome predict the vulnerable plaque in patients with stable angina pectoris? Virtual histology-intravascular ultrasound analysis.
Lee MG; Jeong MH; Kim DH; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
J Cardiol; 2012 May; 59(3):266-74. PubMed ID: 22341056
[TBL] [Abstract][Full Text] [Related]
38. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.
Nicholls SJ; Hsu A; Wolski K; Hu B; Bayturan O; Lavoie A; Uno K; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2010 May; 55(21):2399-407. PubMed ID: 20488313
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.
Kitai Y; Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Yanagita M; Shizuta S; Kimura T;
Int J Cardiol; 2013 Oct; 168(6):5221-8. PubMed ID: 23998544
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of plaque composition by intravascular ultrasound and its relation to distal embolization after percutaneous coronary intervention.
Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Park YA; Cho KI; Park YH; Kim DS
Am J Cardiol; 2013 Apr; 111(7):968-72. PubMed ID: 23351457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
